CANCER CELL COVER

CANCER CELL COVER

Image
Cancer Cell cover

MEDICAL ILLUSTRATION

Client:

Staudt, Louis (NIH/NCI)

Project description:

The so-called “Phoenix” Phase III randomized clinical trial evaluated the benefit of adding the BTK inhibitor ibrutinib to standard R-CHOP chemotherapy in patients with newly diagnosed non-GCB DLBCL.

Manuscript title:

PHOENIX rises: Genomic-based therapies for diffuse large B cell lymphoma
Cancer Cell Volume 39, Issue 12p1549-1654
PMID: 34739844
PubMed
Illustrator: Erina He